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Edited by Stuart FergusonAbstract Methanosarcina barkeri inserts pyrrolysine (Pyl) at
an in-frame UAG codon in its monomethylamine methyltransfer-
ase gene. Pyrrolysyl-tRNA synthetase acylates Pyl onto
tRNAPyl, the amber suppressor pyrrolysine Pyl tRNA. Here
we show that M. barkeri Fusaro tRNAPyl can be misacylated
with serine by the M. barkeri bacterial-type seryl-tRNA synthe-
tase in vitro and in vivo in Escherichia coli. Compared to the M.
barkeri Fusaro tRNA, the M. barkeri MS tRNAPyl contains two
base changes; a G3:U70 pair, the known identity element for
E. coli alanyl-tRNA synthetase (AlaRS). While M. barkeri
MS tRNAPyl cannot be alanylated by E. coli AlaRS, mutation
of the MS tRNAPyl A4:U69 pair into C4:G69 allows aminoacy-
lation by E. coli AlaRS both in vitro and in vivo.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
Keywords: tRNAPyl; Pyrrolysine; Mischarging;
Methanosarcina barkeri1. Introduction
A number of deviations from the universality of the genetic
code are known [1]. One of them is the recoding of in-frame
UAG codons as pyrrolysine (Pyl) sense codons in the Methan-
osarcinaceae, a group of methanogenic archaea, and in two
evolutionarily unrelated bacteria [2,3]. The co-translational
insertion of Pyl is contingent on the presence of the special am-
ber suppressor tRNAPyl (encoded by pylT) [4], and an unusual
aminoacyl-tRNA synthetase (aaRS), pyrrolysyl-tRNA synthe-
tase (PylRS, encoded by pylS), speciﬁc only for this modiﬁed
amino acid [4–6]. PylRS speciﬁcally recognizes Pyl and tRNA-
Pyl [5,6] and generates Pyl-tRNAPyl both in vitro and in vivo.
Transformation of Escherichia coli with the archaeal pylT
and pylS genes showed that both gene products are also func-
tional in a bacterial setting [6–9]. Monitoring of UAG read-
through eﬃciency by various reporter systems indicated that
the stop codon is suppressed only when tRNAPyl and PylRS
are present and the E. coli strain is grown in a culture media*Corresponding author. Address: Departments of Molecular Bio-
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doi:10.1016/j.febslet.2008.08.027containing an exogenous source of Pyl [N-e-cyclopentyloxycar-
bonyl-L-lysine (Cyc), a structural analog of Pyl] [6–9].
The molecular basis of PylRS speciﬁcity towards tRNAPyl
was attributed to the unusual secondary/tertiary structure of
the tRNA [8,10] previously seen only in the bovine mitochon-
drial tRNASer [11,12]. A series of speciﬁc interactions medi-
ated by nucleotides located in the acceptor stem and
ﬂanking the tRNAPylCUA anticodon were also shown to con-
tribute to the recognition of tRNAPyl by PylRS [8,10]. In con-
trast to most aaRSs, PylRS does not recognize its tRNA
substrate via interaction with nucleotides of the anticodon
[8,10,13]. This observation made possible the insertion of
Cyc at a UGA codon upon engineering of a complementary
UCA anticodon in tRNAPyl [10]. Crystallization of Methano-
sarcina mazei PylRS in a complex with Pyl and Cyc allowed
the visualization of the enzymes active site and shed some
light on Pyl recognition by archaeal [13,14] and bacterial Pyl-
RS [15].
In addition to Pyl and Cyc recognition, recent work
describes the engineering of the PylRS active site to accommo-
date the lysine analogs, N-benzyloxycarbonyl lysine and N-
acetyl lysine, so as to allow their incorporation into proteins
in human [16] and E. coli [17] cells.
The tRNAPyl sequences of two Methanosarcina barkeri
strains are known; M. barkeri Fusaro and M. barkeri MS
tRNAPyl diﬀer in two bases (see Fig. 1), but both share the un-
ique tRNA structure with the one found in the Bos taurus
mitochondrial tRNASer species [18]. In these tRNAs the junc-
tion between the acceptor stem and D stem is shortened by one
nucleotide, the anticodon stem consists of six base pairs in-
stead of the classical ﬁve pairs, and the D loop is signiﬁcantly
shorter compared to the canonical cloverleaf structures [5,18].
TheM. barkeriMS tRNAPyl has a G3:U70 base pair; this pair
was shown to be the primary identity element for tRNAAla rec-
ognition by E. coli alanyl-tRNA synthetase (AlaRS) [19,20].
Since the PylRS and tRNAPyl are assumed to be a functional
orthogonal pair for genetic code expansion, we wanted to
study this further by probing the aminoacylation of tRNAPyl
by non-cognate aaRSs.2. Materials and methods
2.1. General
Oligonucleotide synthesis, DNA sequencing and Edman degrada-
tion were performed by the Keck Foundation Biotechnology Resource
Laboratory at Yale University. [14C]Serine (155 mCi/mmol) and
[14C]alanine (150 mCi/mmol) were from Amersham Biosciences (Upp-
sala, Sweden).blished by Elsevier B.V. All rights reserved.








































































































































Fig. 1. Cloverleaf representation of M. barkeri Fusaro tRNAPyl, Bos taurus mitochondrial tRNASer, M. barkeri MS tRNAPyl and M. barkeri
tRNAAla UGC. Diﬀerences in M. barkeri MS tRNA
Pyl are indicated by arrows. The boxes indicate the unusual structure shared by the tRNAs.
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M. barkeri strain Fusaro and strain MS tRNAPyl were produced and
puriﬁed as described in [5]. Minihelices were constructed based on the
sequences of M. barkeri MS tRNAAla (tRNAAla), M. barkeri MS
tRNAPyl (tRNAPyl), and an M. barkeri MS tRNAPyl mutant
(A4:U69ﬁC4:G69) (tRNAPyl C4:G69). The minihelices are shown in
Fig. 4B with their designated names (indicated in parentheses in the
previous sentence). The pGF-1b plasmid containing the E. coli sup-
pressor tRNALys gene was obtained from W. McClain (University of
Wisconsin, Madison). The pET-15b plasmids containing the M. bark-
eri Fusaro bacterial and methanogenic SerRS genes were as described
[21]. The pET15 E. coli AlaRS construct was a gift from M. Frugier
(IBMC, Strasbourg, France).2.3. Aminoacylation assays
Aminoacylation was performed at 37 C in 100 mM Hepes-KOH
pH 7.2, 20 mM MgCl2, 5 mM KCl, 5 mM dithiotreitol, 5 mM ATP,
300 lM [14C]Ser or [14C]Ala, 2 lM tRNA transcript, and 1 lM en-
zyme. Twenty microliters aliquots were taken at 1, 5, 20, 40, and
60 min and spotted onto Whatman ﬁlters (3MM). The ﬁlters were
washed twice with 10% TCA for 15 min each, and once with 5%
TCA for 15 min. The ﬁlters were then rinsed with ethanol and allowed
to dry. Radioactivity was measured with a Beckman Coulter LS 6500
scintillation counter.2.4. TrpA mutant auxotrophy
To determine charging of a tRNAPyl mutant with alanine in vivo, an
E. coli trpA94 strain (amber mutation in position 94 of trpA) was used.
Active TrpA protein can only be made by the insertion of Ala or Gly
into this position [22]. Cells were transformed with pGF-1b plasmid
carrying the tRNAPyl C4:G69 mutant and plated on M9 minimal med-
ium supplemented with ampicillin, either with or without Trp and
grown at 37 C.
2.5. Suppression eﬃciency
Read-through eﬃciency using the dual luciferase/b-galactosidase re-
porter system was performed as indicated earlier [9].
2.6. Suppression of a UAG codon in an E. coli folA reporter gene
A mutant E. coli folA gene (encoding dihydrofolate reductase,
DHFR) containing a UAG codon in place of codon 3 was ampliﬁed
from genomic DNA, cloned into the pCR 2.1-TOPO plasmid vector
(Invitrogen, Carlsbad, CA), sequenced, and subcloned into pRSFDu-
et-1. E. coli BL21(DE3) competent cells were cotransformed with wild-
typeM. barkeri Fusaro tRNAPyl (cloned in pTECH), the folA reporterconstruct (cloned in pRSF) and theM. barkeri bacterial-type SerRS in
pET15b. The resulting strains were grown in Luria broth at 37 C. Pro-
duction of the recombinant DHFR was induced with 1 mM isopropyl-
b-D-thiogalactoside when cells reached an A600 of 0.6. Cells were har-
vested after 17 h. DHFR was puriﬁed using a Ni-NTA aﬃnity column
and then blotted onto a PVDF membrane. The ﬁrst eight amino acids
were identiﬁed by Edman degradation. Background was determined in
the same conditions but in the absence of any overexpressed proteins.
BL21(DE3) competent cells were also cotransformed with wild-type
M. barkeri Fusaro tRNAPyl (cloned in pTECH), the folA reporter con-
struct (cloned in pRSF) and M. barkeri PylRS in pET15b. Cells were
grown in the presence of Cyc, recombinant DHFR was puriﬁed and
sequenced by Edman degradation as indicated above.3. Results and discussion
3.1. Mischarging of M. barkeri Fusaro tRNAPyl with serine
in vitro
The unique secondary structure of M. barkeri Fusaro
tRNAPyl is only shared by mammalian mitochondrial
tRNASerUGA [23] (Fig. 1). Therefore, we investigated whether
tRNAPyl could be a substrate for the two M. barkeri SerRSs.
M. barkeri contains two serS genes that encode two diﬀerent
types of SerRSs: a bacterial-type SerRS present in most organ-
isms, and a highly divergent SerRS only found in some meth-
anogenic archaea [24]. The methanogenic and bacterial-type
SerRSs use overlapping identity elements to recognize the
same set of tRNASer species [21]. In vitro aminoacylation reac-
tions showed that the bacterial-type SerRS was able to acylate
up to 15% of the available M. barkeri tRNAPyl transcript with
serine after 60 min (Fig. 2). In contrast, the methanogenic
SerRS showed no detectable charging of tRNAPyl (Fig. 2).3.2. Mischarging of M. barkeri Fusaro tRNAPyl with serine
in vivo
We then determined whether the mischarging of tRNAPyl
with serine observed in vitro also occurs in vivo. To do so,
we measured the level of UAG read-through in E. coli in the















Fig. 2. Misacylation of M. barkeri Fusaro tRNAPyl with serine
in vitro. tRNAPyl and bacterial-type SerRS (d), tRNAPyl and
















































Fig. 3. Incorporation of serine and Cyc in a b-galactosidase/luciferase
fusion reporter protein. Bars represent UAG read-through eﬃciency:
M. barkeri tRNAPyl and either M. barkeri bacterial like SerRS (B-
SerRS), M. barkeri methanogenic SerRSs (M-SerRS), E. coli SerRS
(Ec-SerRS) or an empty expression vector (pET15 empty). As positive
control,M. barkeri tRNAPyl andM. barkeri PylRS (Mb-PylRS) in the
presence of Cyc was measured. Negative controls include measure-
ments with either M-SerRS or B-SerRS without PylT.
S. Gundllapalli et al. / FEBS Letters 582 (2008) 3353–3358 3355reporter system that contains in frame the genes encoding b-
galactosidase (lacZ) and luciferase (luc). The two genes are
transcribed as a single mRNA unit; an in frame UAG codon
is located between the two open reading frames. In the absence
of read-through only the b-galactosidase is produced. Upon
read-through a b-galactosidase–luciferase fusion protein is
synthesized. Luciferase enzymatic activity directly correlates
to the frequency of read-through, and when normalized to b-
galactosidase activity allows sample-to-sample comparison.
Read-through eﬃciency is expressed as the ratio of luciferase
to b-galactosidase enzymatic activities observed with the in
frame UAG-containing reporter plasmid over the same ratio
obtained when the stop codon is a standard lysine codon. Thisreporter system, previously used to study internal ribosome
reentry sites [25], permits to reliably measure read-through
even when it occurs at very low level.
We quantiﬁed UAG suppression eﬃciency in the presence of
tRNAPyl and each one of the twoM. barkeri SerRSs and com-
pared these values to those obtained with the appropriate neg-
ative and positive controls. When tRNAPyl was co-expressed
with the bacterial-type SerRS, read-through to up to 8.6%
was detected and only to about 3.3% with the methanogenic
SerRS (Fig. 3). In the absence of any overexpressed enzyme,
background read-through was measured as 1.3% (Fig. 3).
These results indicated that when expressed in E. coli the
two M. barkeri SerRSs are able to misacylate M. barkeri
tRNAPyl with serine at a low but detectable level. To gauge
the signiﬁcance of such read-through we compared it with
UAG suppression observed in the presence of PylRS, tRNAPyl
and Cyc, a structural analog of Pyl (Fig. 3). Read-through in
the presence of the bacterial-type SerRS accounted for only
11% of that observed with PylRS and Cyc. The in vivo obser-
vations are in line with our above in vitro results that showed
the ability of the M. barkeri bacterial-like SerRS to serylate
tRNAPyl. More surprising was the fact that we could detect
read-through activity with the methanogenic enzyme while
no aminoacylation could be detected in vitro. We attribute this
apparent discrepancy to the higher sensitivity of the in vivo as-
say for very low mischarging activities. Neither the methano-
gen-type M. barkeri SerRS nor E. coli SerRS formed
signiﬁcant amounts of Ser-tRNAPyl, and suppression was en-
tirely dependent on the presence of tRNAPyl (Fig. 3).3.3. Direct evidence for serine incorporation into protein
Next we sought to conﬁrm the direct insertion of serine into
a reporter protein in E. coli. We utilized an E. coli folA (encod-
ing DHFR) reporter gene containing an in-frame UAG codon
at position 3 and a six-histidine codon repeat at the 3 0 end.
E. coli cells were co-transformed with tRNAPyl, the folA gene
reporter and eitherM. barkeri bacterial-type serS, or an empty
plasmid for background determination. For each condition, a
DHFR-His6 was puriﬁed by Ni-NTA chromatography and
SDS gel electrophoresis. N-terminal sequencing of the puriﬁed
DHFR-His6 from cells co-transformed with the bacterial-type
serS revealed the presence of Ser at position 3 in the protein.
Pro, Gln, and Val were also detected at the third position al-
beit in much smaller amounts. Pro was found to be at position
3 of the protein sample extracted from the cells lacking
tRNAPyl (negative control).
To ensure that our reporter system was functioning properly
we measured the incorporation of Cyc at position 3 of the re-
combinant DHFR-His6 in cells grown on Cyc and containing
the tRNAPyl:PylRS pair. Expression of the DHFR-His6 was
signiﬁcantly higher than in the previous experiments and al-
lowed puriﬁcation of the protein to homogeneity. Amino acid
3 of the puriﬁed DHFR-His6 was identiﬁed as Cyc, in line with
earlier mass spectroscopy data [17]. No other amino acid was
detected in position 3 (data not shown).3.4. Misacylation of M. barkeri MS tRNAPyl with alanine
in vitro
M. barkeri MS tRNAPyl diﬀers from M. barkeri Fusaro
tRNAPyl at two positions: the ﬁrst nucleotide of the variable
loop is U44 instead of C44, and in the acceptor stem MS
3356 S. Gundllapalli et al. / FEBS Letters 582 (2008) 3353–3358tRNAPyl contains a G3 instead of A3 (Fig. 1). The G3A devi-





























































































Fig. 4. Misacylation ofM. barkeriMS tRNAPyl with alanine in vitro. (A) In v
tRNA with E. coli AlaRS (n),M. barkeriMS tRNAPyl with E. coli AlaRS (m)
right, M. barkeri MS tRNAAla (tRNAAla), M. barkeri MS tRNAPyl (tRNAP
vitro aminoacylation of minihelices. MS tRNAAla minihelix with E. coli AlaR
C4:G69 mutant minihelix with E. coli AlaRS (r).A G3:U70 pair is also the primary identity element for








































itro aminoacylation of wild-typeM. barkeriMS tRNAPyl. Total E. coli
, no enzyme (r). (B) Minihelices based on the sequences of, from left to
yl), M. barkeri MS C4:G69 tRNAPyl mutant (tRNAPyl C4:G69). (C) In
S (d), MS tRNAPyl minihelix with the E. coli AlaRS (m), MS tRNAPyl
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substrate for E. coli AlaRS. As seen in Fig. 4A, the M. barkeri
MS tRNAPyl is not misacylated with alanine by E. coli AlaRS
in vitro, possibly the result of a tRNA anti-determinant whose
presence prevents AlaRS recognition. A good candidate for an
anti-determinant in wild-type MS tRNAPyl is the A4:U69 base
pair, as insertion of A4:U69 into tRNAAla disrupts the accep-
tor stem helix and reduces recognition by AlaRS [19]. We
tested whether this particular base pair plays a role in preclud-
ing MS tRNAPyl from being misacylated with alanine by
E. coli AlaRS. Inspection of the M. barkeri MS tRNAAla se-
quence revealed a C4:G69 base pair underneath the G3:U70
main identity element. We decided to replace M. barkeri MS
tRNAPyl A4:U69 with a C4:G69 pair. AlaRS is one of the
few aaRSs shown to be able to charge stem-loop helices de-
rived from its cognate tRNAAla [26]. We then constructed
three minihelices (Fig. 4B) based on (i)M. barkeriMS tRNAAla
(tRNAAla), (ii) acceptor and T-stem sequences of M. barkeri
MS tRNAPyl (tRNAPyl), and (iii) a C4:G69 M. barkeri MS
tRNAPyl mutant (tRNAPyl C4:G69). The M. barkeri
MS tRNAPyl minihelix, like the full length tRNAPyl is not mis-
acylated by E. coli AlaRS. The control M. barkeri MS wild-
type tRNAAla stem-loop helix was charged close to 50%. The
C4:G69 mutant minihelix was acylated with Ala but remained
a poor substrate for AlaRS since it was charged to only 2%
(Fig. 4C).
3.5. Misacylation of M. barkeri MS tRNAPyl with alanine
in vivo
To determine whether M. barkeri MS tRNAPyl and its
C4:G69 mutant can be misacylated with Ala in vivo, we made
use of the E. coli trpA94 amber mutant strain that will only
grow in the absence of exogenously added Trp is the amber co-
don is suppressed by either Gly or Ala [22]. We transformed
this strain with plasmids containing either the M. barkeri MS
wild-type tRNAPyl, the C4:G69 tRNAPyl mutant, an E. coli
tRNAAla amber suppressor, or an empty vector. The trans-
formed strains were plated on M9 minimal medium with or
without Trp (Fig. 5).
After incubation at 37˚C for 72 h, the E. coli strain trpA94
transformed with the tRNAPyl C4:G69 mutant showed growth
on plates without Trp, albeit at a slower rate (72 h) compared1 2 1 2
3 4 3 4
A B
Fig. 5. Suppression of an E. coli strain trpA94 with theM. barkeriMS
tRNAPyl C4:G69 mutant. E. coli transformants were streaked on M9
medium (A) with Trp (B) without Trp. E. coli transformed with 1,
C4:G69 M. barkeri MS tRNAPyl mutant; 2, M. barkeri MS tRNAPyl
wild-type; 3, empty plasmid; 4, tRNAAla amber suppressor.to the E. coli tRNAAla amber suppressor (24–48 h) (Fig. 5).
This result indicated the misacylation of the mutant tRNAPyl
with Ala, and the production of a suﬃcient amount of active
TrpA enzyme, permitting cell survival. The cells transformed
withM. barkeriMS wild-type tRNAPyl or with the empty plas-
mid did not show any growth after 72 h (Fig. 5), conﬁrming
our in vitro results. Lastly, as expected, all transformants grew
on minimal plates supplemented with Trp (Fig. 5).4. Outlook
The current study demonstrates two instances of tRNAPyl
misacylation, the formation of Ser-tRNAPyl and Ala-tRNAPyl.
M. barkeri bacterial-type SerRS recognizes its three tRNASer
isoacceptors via interaction of amino acids in the long a-helix
domain with nucleotides of the extended variable loop of the
tRNASer; this speciﬁcity mechanism is shared with E. coli
SerRS [21]. Bovine mitochondrial tRNASer lacks such an ex-
tended variable loop and presents a non-canonical structure;
a mitochondrial SerRS:tRNASer complex requires an addi-
tional N-terminal enzyme domain interacting with nucleotides
of the D-and T-loops [23]. Future studies will establish details
of the interaction between SerRS and tRNAPyl, and should
also provide more insight into possible uses of misacylated
suppressor tRNAPyl in protein synthesis.
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